tiprankstipranks
Eton Pharmaceuticals Inc (ETON)
NASDAQ:ETON
US Market
ETON
Eton Pharmaceuticals
RESEARCH TOOLSreports

Eton Pharmaceuticals (ETON) Stock News & Sentiment

546 Followers
Eton Pharmaceuticals Maps Aggressive Rare-Disease Growth Path
Premium
Company Announcements
Eton Pharmaceuticals Maps Aggressive Rare-Disease Growth Path
22d ago
ETON
Eton Pharmaceuticals: Expanding Rare-Disease Portfolio Underpins Attainable Growth Targets and Upside to $52 Price Target
Premium
Ratings
Eton Pharmaceuticals: Expanding Rare-Disease Portfolio Underpins Attainable Growth Targets and Upside to $52 Price Target
22d ago
ETON
Is ETON a Buy, Before Earnings?
Premium
Pre-Earnings
Is ETON a Buy, Before Earnings?
25d ago
ETON
Eton Pharmaceuticals Acquires U.S. Rights to HEMANGEOL
Premium
Company Announcements
Eton Pharmaceuticals Acquires U.S. Rights to HEMANGEOL
1M ago
8K
ETON
Eton Pharmaceuticals Wins FDA Approval for DESMODA Therapy
Premium
Company Announcements
Eton Pharmaceuticals Wins FDA Approval for DESMODA Therapy
1M ago
8K
ETON
Eton Pharmaceuticals Licenses U.S. Rights to Ultra-Rare Drug
Premium
Company Announcements
Eton Pharmaceuticals Licenses U.S. Rights to Ultra-Rare Drug
2M ago
8K
ETON
Eton Pharmaceuticals: Promising Growth Trajectory with Projected Revenue Surge and Strategic Developments
Premium
Ratings
Eton Pharmaceuticals: Promising Growth Trajectory with Projected Revenue Surge and Strategic Developments
4M ago
ETON
More ETON News >

ETON News on the Web

Opaleye Management Inc. Increases Stake in Sol-Gel Technologies Ltd
GuruFocus News
Neutral
Opaleye Management Inc. Increases Stake in Alpha Cognition Inc.
GuruFocus News
Neutral
Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock?
Zacks
Bullish
Recent Price Trend in Eton Pharmaceuticals (ETON) is Your Friend, Here's Why
Zacks
Bullish
Eton Pharmaceuticals Maps Aggressive Rare-Disease Growth Path
TipRanks News
Bullish
Eton Pharmaceuticals price target raised to $52 from $37 at H.C. Wainwright
TipRanks News
Bullish
Eton Pharmaceuticals: Expanding Rare-Disease Portfolio Underpins Attainable Growth Targets and Upside to $52 Price Target
TipRanks News
Bullish
Does Eton Pharmaceuticals (ETON) Have the Potential to Rally 49.25% as Wall Street Analysts Expect?
Zacks
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ETON’s Media Buzz Sentiment?
Currently, no data Available
What is ETON’s weekly average amount of articles?
Currently, no data Available
What is ETON’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week